Full Description
SMART Vaccines—Strategic Multi-Attribute Ranking Tool for Vaccines—is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I.
Ranking Vaccines: A Prioritization Software Tool,Phase II extends the proof-of-concept presented in the Phase I report, which was based on multi-attribute utility theory. This report refines a beta version of the model developed in the Phase I report and presents its next iteration, SMART Vaccines 1.0.
Ranking Vaccines: Phase II discusses the methods underlying the development, validation, and evaluation of SMART Vaccines 1.0. It also discusses how SMART Vaccines should—and, just as importantly, should not—be used. The report also offers ideas for future enhancements for SMART Vaccines as well as for ideas for expanded uses and considerations and possibilities for the future.
Table of Contents
Front Matter
Summary
1 Introduction: New Vaccines and SMART Vaccines
2 Refinements to the SMART Vaccines Model
3 Data Synthesis, Software Redesign, and Evaluation
4 Observations and Looking Forward
References
Appendix A: Computational Modeling for SMART Vaccines
Appendix B: Candidate Disease Profiles
Appendix C: Data Sources and Methodology for SMART Vaccines
Appendix D: Verification and Analyses of the SMART Vaccines Computational Model
Appendix E: Stakeholder Speakers
Appendix F: Biographical Information
Contents
1 Front Matter; 2 Summary; 3 1 Introduction: New Vaccines and SMART Vaccines; 4 2 Refinements to the SMART Vaccines Model; 5 3 Data Synthesis, Software Redesign, and Evaluation; 6 4 Observations and Looking Forward; 7 References; 8 Appendix A: Computational Modeling for SMART Vaccines; 9 Appendix B: Candidate Disease Profiles; 10 Appendix C: Data Sources and Methodology for SMART Vaccines; 11 Appendix D: Verification and Analyses of the SMART Vaccines Computational Model; 12 Appendix E: Stakeholder Speakers; 13 Appendix F: Biographical Information
